Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00126854
NCT00126854CompletedNot Applicable

High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation

AHS Cancer Control Alberta1 site in 1 country10 target enrollmentStarted: October 1, 2005Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
10
Locations
1
Primary Endpoint
pilot study meant to establish scanning parameters on 3T MRSI
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate gland before and after brachytherapy implantation for prostate cancer. Three Tesla MRSI may be a valuable additional diagnostic and follow-up investigation for prostate cancer patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Suitable candidate for prostate brachytherapy to treat prostate cancer
  • •Patient signs a study consent form

Exclusion Criteria

  • •Have received other radiotherapy for prostate cancer or hormone treatments
  • •Has contraindication to MRSI scanning
  • •Does not sign study consent form

Outcomes

Primary Outcomes

pilot study meant to establish scanning parameters on 3T MRSI

Secondary Outcomes

  • safety/toxicity

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External ProbeHealthy
NCT00314535AHS Cancer Control Alberta40
Completed
Not Applicable
Pulse Sequence Development on 3T Magnetic Resonance Imaging/SpectroscopyHealthy
NCT00309504AHS Cancer Control Alberta40
Withdrawn
Not Applicable
3T MRI Versus MR Arthrogram in SLAP LesionsSuperior Labrum Anterior Posterior Lesion
NCT01896947Henry Ford Health System
Completed
Not Applicable
Optimization of a new 3 Tesla Magnetic Resonance Imaging protocol to vizualize the coronary arteries and aorta1001108210003216atherosclerosis
NL-OMON36337niversitair Medisch Centrum Utrecht80
Terminated
Not Applicable
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of ProstateProstate Cancer
NCT00429338M.D. Anderson Cancer Center8